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RISK FACTORS, DIAGNOSIS AND CURRENT TREATMENT OF 
ACANTHAMOEBA KERATITIS 
Acanthamoeba keratitis is a relatively rare, but devastating infection of 
the cornea caused by amoeba of the genus A canthamoeba. Laboratory and 
clinical diagnosis will be discussed, along with the risk factors associated with 
contracting this infection. Current treatment regimens available and the 
efficacy of these treatments will be examined. 
Acanthamoeba keratitis is a relatively rare, but devastating 
infection of the cornea caused by a free-living protozoan of the genus 
Acanthamoeba. These amoeba have a ubiquitous distribution, found 
in the soil, water, and air.l Acanthamoeba species have been found m 
all types of water, including tap, fresh, "distilled", well, and sea 
water, hot tubs, swimming pools, and saliva. Thus, it is nearly 
impossible to avoid some type of contact with the organism.2,3 
Several species have been identified in infected eyes: A. culbertsoni, 
A. polyphaga, A. rhysodes, A. hatchetti, and the most frequently 
found, A. castellani. The organism exists in two forms, a trophozoite 
state in which rapid growth takes place, and a protective cyst state 
that occurs under unfavorable conditions. When Acanthamoeba is 
exposed to adverse conditions, it converts to a cyst that it is resistant 
to freezing, drying, standard chlorination of water, and is capable of 
survival in a wide range of temperatures and pH.4 
Although Acanthamoeba keratitis is relatively rare, there has 
recently been an increase of reported cases seen in the literature. 
This increase in cases has been associated with the parallel rise in 
the number of contact lens wearers. 
RISK FACTORS 
Risk factors for acquiring this infection are predominantly 
contact lens wear and minor environmental trauma.5 Several 
theories have been postulated relating to the increased incidence of 
Acanthamoeba keratitis in contact lens wearers, the majority of 
patients were soft contact lens wearers. 
1.) Contact lens wear may increase the possibility of 
contracting an Acanthamoeba infection by providing a point of entry 
for the amoeba, as it has been proven that the integrity of the 
corneal epithelium may be compromised in contact lens wear.2 Soft 
contact lens wear may induce mechanical or hypoxic epithelial 
trauma, which may increase the ability of the organisms to gain a 
foothold onto the cornea. 
2.) The use of home prepared saline has been cited as a mode 
for contamination of the cornea with Acanthamoeba. Both distilled 
and tap water used in combination with salt tablets to make saline, 
have been found to contain the amoeba cysts,6 which can then gain 
access to the cornea upon application of the contact lens. 
3.) Swimmers and hot tub users who fail to disinfect their 
lenses after swimming are at risk of contracting Acanthamoeba 
keratitis, as normal chlorination fails to kill the amoeba cysts.3 
4.) Persons who place their contact lenses in their mouth and 
then back in the eye are also at risk, as Acanthamoeba has been 
isolated from the nasopharynx of healthy individuals. However, it 1s 
not known whether a contact lens contaminated with saliva can 
result in Acanthamoeba keratitis.2 
CLINICAL DIAGNOSIS 
Contact lens weanng Acanthamoeba keratitis victims tend to 
have several common characteristics. The patients tend to be young 
and healthy, keep their contact lenses in home-prepared saline 
made from distilled water, have no history of trauma immediately 
prior to the development of the keratitis, and have a unilateral 
infection. Symptoms reported by patients with Acanthamoeba 
keratitis usually include a foreign-body sensation, blurred vision, 
tearing, photophobia, and severe pain that seems out of proportion to 
the clinical signs. A reactive upper lid ptosis may also be present.l-7 
Early epithelial infections alone may present with any of 
several clinical signs, including corneal abrasions, punctate 
keratopathy, recurrent epithelial defects, pseudodendrites, or 
microcysts.2 The characteristic Acanthamoeba keratitis signs that are 
typically present include a central or paracentral ring-like infiltrate, 
recurrent epithelial breakdown, marked iritis with occasional 
hypopyon, and often including increased intraocular pressure, 
scleritis, corneal hypoesthesia, and hyphema.4,8 The clinical 
progression of the disease begins somewhat as a resemblance of 
herpes simplex epithelial dendrites. The pathognomonic sign for 
Acanthamoeba is the presence of infiltrates around the corneal 
nerves.9 Acanthamoeba keratitis can mimic herpes simplex 
infections, and to a smaller degree, certain bacterial and fungal 
infections.lO Thus, it is imperative that the correct diagnosis be made 
as soon as possible so that appropriate therapy may be initiated. 
LABORATORY DIAGNOSIS 
To make an etiological diagnosis of Acanthamoeba keratitis, it 
is necessary to perform tests that are specific for these organisms, as 
routine examination will often miss finding them. Corneal samples 
can be cultured for Acanthamoeba on a nonnutrient agar with an E. 
coli overlay. Material from the plate is examined using a Giemsa or 
Wright stain, as a Gram stain usually fails to identify Acanthamoeba 
organisms. Growing Acanthamoeba in culture may take anywhere 
from a few days to weeks, thus delaying proper diagnosis and 
medical therapy. Corneal scrapings are also taken as a routine 
procedure on any suspect Acanthamoeba infection, and Giemsa or 
Wright stains are used in the identification of these organisms.lO A 
negative corneal scraping (usually just epithelial cells) does not rule 
out the presence of Acanthamoeba, as the organisms may be located 
in the corneal stroma. A corneal biopsy of the stromal tissue may be 
necessary for a culture and histology examination if no Acanth-
amoeba is found prior, or if there is no epithelial involvement, only 
stromal. 8 
If the keratitis is active, trophozoites would be expected m the 
specimens, but they tend to be very fragile and rupture upon air-
drying. The trophozoites often resemble mononuclear cells or 
degenerating epithelial cells, thus making identification with Giemsa, 
Gram's, or Wright's stain difficult.ll The trophozoites may be 
examined by suspension in Page's saline using light or phase-contrast 
microscopy. They are slowly moving and leave "amoebic" trails on 
the plated media. However, other cell types, such as epithelial cells 
and macrophages, can leave similar trails. 
Research for specific diagnostic tests for trophozoite recognition 
has not been actively pursued, however, as the cysts are readily 
identified .12 One quick and precise method of identifying 
Acanthamoeba cysts is through the use of calcofluor white stain 
which stains the cyst wall. Using this stain and fluorescent 
microscopy, the trophozoites appear bright red-orange, and the cyst 
cell walls fluoresce bright "apple-green" with red-orange cytoplasm. 
The cysts can readily be identified, as keratocytes, mononuclear cells, 
lymphocytes, and epithelium do not fluoresce. This 1s a quick and 
easy method to identify Acanthamoeba organisms.ll 
Another laboratory method of identifying Acanthamoeba 
organisms which is very specific is the use of the indirect fluorescent 
antibody staining technique. A corneal scraping or biopsy is taken 
and fixed. The exact fixation method to be used has not been 
established, however, 10% buffered formalin preserves the integrity 
of both cysts and trophozoites.13 The slide is "stained" using specific 
antibodies that have been "tagged" with fluorescein. The slide is 
then examined under a fluorescent microscope for the presence of 
fluorescent Acanthamoeba cysts or trophozoites. 
TREATMENT 
No treatment of choice has yet been established for 
Acanthamoeba keratitis. The trophozoites are susceptible to some 
drugs, but the cysts are resistant to most drugs in concentrations that 
are safe and achievable in the cornea2,8, including the most used 
antibacterial, antifungal, antiprotozoal, and antiviral agents that are 
currently available.14 Since diagnosis is often delayed, the infection 
can be quite advanced by the time medical therapy is initiated. 
Therapy is difficult, and the differing degrees of pathogenicity of the 
vanous strains adds more to the complexity of the treatment 
evaluation.4 
Patients are often hospitalized for treatment once 
Acanthamoeba keratitis has been diagnosed, and medical therapy is 
immediately initiated. 15 Because of the persistance of cysts for up to 
a year in the laboratory and thus, perhaps in the cornea, medical 
treatment is continued for at least a year. 
Most of the current medical treatment regimens focus on the 
following drugs used in combination: polymyxin B-neomycin-
gramicidin (e.g., Neosporin); propamidine isethionate 0.1% (e.g., 
Brolene) which can be obtained over the counter in Britain but 
requires FDA approval in the U.S.; clotrimazole 1%, miconazole 1%, or 
paromomycin; oral ketoconazole. A cycloplegic is usually also 
administered to control the often associated uveitis, and a 
nonsteroidal antiinflammatory agent (e.g., Sulindac) is given for pain 
and scleritis.l5 Clotrimazole is not currently available in an 
ophthalmic solution, but in powder form, can be mixed in artificial 
tears. No drug has been consistently effective against the 
Acanthamoeba cyst.I6 
If medical therapy fails, a corneal transplant may be indicated. 
However, the best time for penetrating keratoplasty (PK) remains 
controversial. Indications for an emergent PK is descemetocele 
formation or perforation. But as far as other indications for PK, there 
are no set guidelines, and decisions must be made by looking at each 
case individually. Literature case reports have shown that PK tends 
to have a higher success rate if performed prior to extensive damage 
caused by the organism disseminating throughout the cornea. If the 
infection is localized to a relatively small area, a PK may allow 
complete or nearly complete removal of the organism, and thus a 
nonimmunocompromised patient will have a better chance of 
supporting the new graft and fight off any residual organisms.9 If 
however, the cornea has undergone extensive corneal damage, it has 
been suggested that extensive medical therapy occur pnor to PK to 
eliminate as much of the Acanthamoeba as possible. 
Elective PK has been advocated for infections that are 
progressive, fail to respond to medical therapy, or continue in a 
waxing and waning course. Case reports have shown an increased 
likelihood of preserving useful vision if elective surgery is performed 
within four months of onset, but a higher possibility of graft rejection 
is likely.4 
Some authorities suggest that keratoplasty should be 
attempted early in the course of the disease so as to decrease the 
amount of corneal involvement with the organism, while others 
stating that it is best to wait until the eye is quiet with the use of 
medical therapy before PK is performed. Thus, the controversy 
continues. 
The use of steroids m the treatment of Acanthamoeba keratitis 
Is also controversial. Experiments have shown that the use of 
steroids inhibits the transformation of trophozoites to cysts (and vice 
versa), which may increase the susceptibility to anti-amoebic drugs 
by preventing the trophozoites to go to the more resistant cyst form. 4 
However, Drs. Mary Beth Moore and James P. McCulley do not 
advocate the use of topical steroids in the management of 
Acanthamoeba keratitis. Their opinion is that the host defenses, 
neutrophil and macrophage responses, that play an important role m 
eradicating the organism are inhibited with the use of steroids.? 
When the keratitis is limited to the epithelium, epithelial 
debridement early in the course of the disease, combined with 
topical medication has led to successful treatment in some cases. The 
preferred drugs are 0.15% dibromopropamide (Brolene ointment) 
and 0.1% propamidine isethionate (Brolene drops). The most 
effective dosage has not been determined, but currently, the drops 
and ointment are administered on an hourly basis at the beginning of 
therapy. It has been recommended that after one week of intense 
topical therapy with Broline, the dosage be decreased to four times a 
day, because superficial necrosis of granulation tissue can occur.4 
PREVENTION 
Human exposure to Acanthamoeba cannot be eliminated; 
however, ocular exposure while wearing contact lenses can be 
reduced. Patient education is a necessity to increase the awareness 
of the possibility of ocular infections. It should be emphasized to 
patients that they should not wear their contact lenses while in hot 
tubs or swimming pools, as normal chlorine levels have been unable 
to kill Acanthamoeba cysts. The use of home-made saline and 
enzyme cleaners that are dissolved in distilled water should be 
avoided. Good contact lens hygiene should be stressed to decrease 
the likelihood of contracting Acanthamoeba keratitis, or any other 
type of ocular infection. I 7 
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